
    
      This clinical trial was conducted in a qualified clinical trial institution. Investigators
      will use WeFlow-JAAA Stent Graft System manufactured by EndoNom Medtech (Hangzhou) Co., Ltd.
      to treat patients with juxta renal abdominal aortic aneurysms. This is a Prospective,
      single-center, first in man study to evaluate the safety and effectiveness of abdominal aorta
      stent graft system in the treatment of patients with juxta renal abdominal aortic aneurysms.
      Follow-up will be conducted before discharge, 30 days after surgery, 6 months after surgery
      and 12 months after surgery.
    
  